The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).

Romualdi, D., De Cicco, S., Busacca, M., Gagliano, D., Lanzone, A., Guido, M., Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study, <<JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION>>, 2013; 36 (8): 636-641 [http://hdl.handle.net/10807/53435]

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

Romualdi, Daniela;De Cicco, Simona;Lanzone, Antonio;Guido, Maurizio
2013

Abstract

The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).
Inglese
Romualdi, D., De Cicco, S., Busacca, M., Gagliano, D., Lanzone, A., Guido, M., Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study, <<JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION>>, 2013; 36 (8): 636-641 [http://hdl.handle.net/10807/53435]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/53435
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 20
social impact